Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01203423 · ClinicalTrials.gov registry record

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

A clinical trial, sponsored by NICHD Neonatal Research Network.

Completed
Registry status
385
Enrollment target

NCT01203423: Completed study, sponsored by NICHD Neonatal Research Network.

NCT01203423 is a clinical trial that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 385 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01203423 has completed, sponsored by NICHD Neonatal Research Network.

COMPLETED
Registry status
385 participants
Enrollment target

Study Summary

This study was an observational study to estimate the prevalence of Persistent pulmonary hypertension of the newborn (PPHN) among term or near-term infants with severe respiratory disease.

Trial Details

FieldValue
Enrollment Target 385 participants
Start Date 1993-10
Est. Completion 1994-12
NICHD Neonatal Research Network

61 total trials

What the finished NCT01203423 record still lists

NCT01203423 is an observational study that tracks outcomes without assigning an intervention. The registered 385 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01203423 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01203423 about?

NCT01203423 is a clinical study titled "Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study". This study was an observational study to estimate the prevalence of Persistent pulmonary hypertension of the newborn (PPHN) among term or near-term infants with severe respiratory disease.

What is the current status of trial NCT01203423?

This trial is currently completed. The enrollment target is 385 participants. The study started on 1993-10. Estimated completion is 1994-12.

Who is sponsoring clinical trial NCT01203423?

This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05373823 · 385 participants · NA

    MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors

  • NCT05503173 · 385 participants · NA

    Telehealth for Pain and Unhealthy Drinking Among PLWH

  • NCT06226883 · 385 participants · Phase 2

    A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  • NCT06290063 · 385 participants · Phase 2

    Cannabidiol and Older Adult Cannabis Users

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01203423, the US trial registry maintained by the National Library of Medicine. NCT01203423 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.